Investigation into the bioequivalence of a new allopurinol tablet formulation compared with a standard preparation;UNTERSUCHUNGEN ZUR BIOAQUIVALENZ EINER NEUEN ALLOPURINOL-TABLETTENFORMULIERUNG IM VERGLEICH ZU EINER REFERENZFORMULIERUNG

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 11, 1997, Pages 1236-1241

  Metzner, Jürgen E ^a   Buchberger, Dietmar ^b   Läuter, Jürgen ^c   Pech, Reinhard ^a  

^a Galmed GmbH   (Germany)

^b ct Arzneimittel Chemische T   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Allo 300 von ct; Allopurinol, bioequivalence, clinical studies; Antigout agent; CAS 315 30 0; Oxipurinol

Indexed keywords

ALLOPURINOL; OXIPURINOL; ANTIMETABOLITE;

ADULT; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SAFETY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TABLET FORMULATION; ULTRAVIOLET SPECTROPHOTOMETRY; AREA UNDER THE CURVE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CROSSOVER PROCEDURE; PHARMACOKINETICS; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALLOPURINOL; ANTIMETABOLITES; AREA UNDER CURVE; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; OXYPURINOL; THERAPEUTIC EQUIVALENCY;

EID: 0031262190     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gröning, R., Dtsch. Apoth. Ztg. 126, 965 (1986)
2. Graham, S., Day, R. O., Wong, H. et al., Br. J. Clin. Pharmacol. 41, 299 (1996)
3. Day, R. O., Birkett, D. J., Hicks, M. et al., Drugs 48, 339 (1994)
4. de Vries, J. X., Voss, A., Ittensohn, A. et al., Clin. Investig. 72, 1076 (1994)
5. Walter-Sack, I., de Vries, J. X., Kutschker, C. et al., Eur. J. Clin. Pharmacol. 49, 215 (1995)
6. Forth, W., Henschler, D., Rummel, W. et al. (eds.), Allgemeine und spezielle Pharmakologie und Toxikologie, 7th edition, B.I.-Wiss. Verlag, Mannheim-Leipzig etc. (1996)
7. Mutschler, E., Arzneimittelwirkungen, 7. Auflage, Wiss. Verlagsgesellschaft mbH, Stuttgart (1996)
8. Reynolds, J. E. F., Parfitt, K., Parsons, A. V. (eds.), Martindale - The Extra Pharmacopoeia, 31. Aufl., S. 419-421, Royal Pharmaceutical Society, London (1996)
9. Pech, R., Validation Report, galmed 0995-37, Halle (1996)
10. de Vries, J. X., Voss, A., Kutschker, C. et al., Arzneim.-Forsch./Drug Res. 43 (II), 1072 (1993)
11. Heinzel, G., Woloszcak, R., Thomann, P., TopFit, Version 2.0. Gustav-Fischer-Verlag, Stuttgart-Jena etc. (1993)
12. SAS-Institute Inc., SAS/STAT, Release 6.3. Carry, NC, USA (1988)
13. CPMP Working Party on the Efficacy of Medicinal Products, Note for Guidance: Investigations of Bioavailability and Bioequivalence (1991), in: Feiden (ed.), Arzneimittelprüfrichtlinien, Wiss. Verlagsgesellschaft, Stuttgart (1997)
14. Blume, H., Mutschler, E. (eds), Bioäquivalenz-Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel, Teil 1/ I, Allopurinol, 1. Ergänzungslieferung, Govi-Verlag Pharmazeutischer Verlag, Frankfurt/Main-Eschborn (1996)